Overview

A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to assess the safety and efficacy of 3 concentrations of BBI-4000 and vehicle (4 treatment arms), applied for the treatment of axillary hyperhidrosis.
Phase:
Phase 2
Details
Lead Sponsor:
Brickell Biotech, Inc.